Keyword: South Korea

Opdivo is priced in China at half its U.S. cost; Novartis names new chief for scandal-hit Korea unit; GSK's Indian consumer unit attracts new buyers.

An ongoing criminal trial in Korea alleges that Novartis used medical journals to funnel kickbacks to doctors.

Multinational pharma companies have all together closed 16 manufacturing plants in South Korea over the past 20 years, local media reports.

South Korea's PRP has acquires a 6,000 meter plant that can produce 2 million vials of the generic ingredient used in wrinkle fighter Botox.

It's believed that SK Chemicals is stealing shingles vaccine share from Zostavax by undercutting the pharma giant's price.

Astellas buys Universal Cells, Teva is affected by Celltrion's manufacturing problem, Korea rolls out a digital health initiative.

A Korean drug company has received a warning letter after FDA inspectors determined it had no quality checks and was handling manufacturing by phone.

South Korean drugmaker gets a U.S. regulatory warning, new results in Takeda and Myovant’s trial for relugolix to treat uterine fibroids and more.

Dasan E&T was handed an FDA warning letter based on an inspection earlier this year that found numerous testing and manufacturing issues at its plant.

South Korean drug manufacturer Firson was slapped with a warning letter and placed on an import alert by the FDA.